The ABCDE rule is a five-point checklist for reading moles: asymmetry, border, color, diameter, and evolving change. Dermatology groups treat it as a first filter, not a diagnosis. A 2004 review in JAMA added the final letter, finding that change over time matters as much as looks.
Skin checks sit alongside other routine screens in a prevention plan. mammography follows a similar screening-first logic for another part of the body. The shared caveat: a checklist raises flags, and a clinician reads them.
This guide covers each letter, what major skin-health bodies advise, and which changes call for a visit. The site's prevention guides keep the rest of routine care in one place.
What the Five Letters Stand For
The American Academy of Dermatology's patient guidance lays out the letters, and the National Cancer Institute describes the same rule in its mole fact sheet. Each letter names a feature linked to early melanoma, a cancer of pigment cells. Per the AAD:
- A is for asymmetry: one half of the spot looks unlike the other half
- B is for border: the edge is irregular, scalloped, or poorly defined
- C is for color: shades vary across the spot, from tan, brown, or black to white, red, or blue
- D is for diameter: melanomas are usually larger than 6 millimeters, about the size of a pencil eraser, though smaller ones occur
- E is for evolving: the spot looks different from the rest or is changing in size, shape, or color
The last letter carries special weight. An evolving spot is one that changes in size, shape, or color, or simply looks different from its neighbors. Familiarity with the skin makes the comparison possible. This connects to our earlier piece, Sunscreen and Skin Cancer Prevention: What the Evidence Supports.
What Dermatology Bodies Say About Self-Checks
The AAD advises consulting a dermatologist immediately when a mole or pigmented spot shows any of the five features. The National Cancer Institute widens the net: people should tell a doctor about any new mole or any change in an existing one. Neither body frames the check as a one-time exercise.
Tracking beats memory, per the NCI's fact sheet. People or their doctors sometimes photograph dysplastic nevi, so change is easier to see. A dysplastic nevus is a mole that looks different from a common one, sometimes called atypical. With more than five of them, doctors may schedule a yearly skin exam.
Where the Rule Came From and What It Misses
The ABCD letters date to 1985, per a 2004 review in JAMA led by researchers at the New York University School of Medicine. That review kept the 6-millimeter diameter guide. It backed adding E for evolving, because change over time outweighs appearance.
The same analysis flagged a known gap: melanomas of 6 millimeters or less exist. Size alone misses them. The AAD's guidance agrees, noting melanomas can be smaller than the pencil-eraser benchmark when diagnosed. Change carries the weight that diameter cannot.
What Remains Uncertain
The rule is a filter, and its limits are on the record. Data in the 2004 review did not support lowering the 6-millimeter threshold, yet small lesions still turn dangerous. No single letter predicts risk on its own. The checklist works as a set.
How often healthy skin should be checked has no fixed answer in the sources. The NCI ties exam frequency to risk instead: yearly exams with many dysplastic nevi, and every 3 to 6 months when melanoma runs in the family. Everyone else starts from knowing their own skin. Change is the signal worth tracking.
When to See a Dermatologist About a Mole
Routine review makes sense for people with many moles, dysplastic nevi, or a family history of melanoma, since the NCI links each to higher risk. A first visit can also set a baseline. Photographs taken at that visit make future comparisons honest.
The NCI's list of warning changes runs from color change and uneven growth to a dry or scaly surface, hardening or lumpiness, and moles that itch, bleed, or ooze. The AAD compresses the same advice: consult a dermatologist immediately when any letter shows. Waiting out a bleeding or itching mole is not part of any guidance.
Conclusion: Five Letters That Buy Time
The ABCDE rule turns mole-watching into five concrete questions, with evolving change carrying the most weight. The framework is old but stable: the 1985 criteria held up, and the 2004 JAMA review refined rather than replaced them. Dermatologists supply the judgment the letters cannot. A checklist plus a low threshold for review is the whole method. For related coverage, see Lung Cancer Screening: Who Qualifies for the Annual Low-Dose CT Scan.
